Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7851
CALL
Yext
YEXT
$641M
| $602K | ﹤0.01% |
62,600
+6,000
| +11% | +$46.2K |
|
|
CAMP
7852
DELISTED
CalAmp Corp.
CAMP
| $601K | ﹤0.01% |
7,284
-830
| -10% | -$81.1K |
|
7853
CALL
Ryman Hospitality Properties
RHP
$8.79B
| $601K | ﹤0.01% |
6,700
-14,300
| -68% | -$1.27M |
|
7854
Haleon
HLN
$43.3B
| $601K | ﹤0.01% |
73,797
-873,733
| -92% | -$6.96M |
|
|
PEO
7855
CALL
Adams Natural Resources Fund
PEO
$798M
| $600K | ﹤0.01% |
30,352
+831
| +3% | +$17.1K |
|
7856
Invesco DB Base Metals Fund
DBB
$365M
| $600K | ﹤0.01% |
29,717
+5,414
| +22% | +$111K |
|
7857
CALL
Core Laboratories
CLB
$578M
| $600K | ﹤0.01% |
27,200
+4,500
| +20% | +$105K |
|
7858
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$307M
| $600K | ﹤0.01% |
+6,614
| New | +$635K |
|
7859
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
| $600K | ﹤0.01% |
+10,076
| New | +$598K |
|
7860
PUT
Treace Medical Concepts
TMCI
$296M
| $600K | ﹤0.01% |
23,800
+10,900
| +84% | +$256K |
|
7861
PUT
Vuzix
VUZI
$249M
| $599K | ﹤0.01% |
144,700
-23,600
| -14% | -$106K |
|
7862
Bionano Genomics
BNGO
$14.1M
| $599K | ﹤0.01% |
899
-2,368
| -72% | -$2.1M |
|
7863
AllianzIM U.S. Equity Buffer10 Dec ETF
DECT
$128M
| $599K | ﹤0.01% |
23,581
+9,808
| +71% | +$244K |
|
7864
PUT
Monro
MNRO
$377M
| $598K | ﹤0.01% |
12,100
+5,700
| +89% | +$283K |
|
|
AGNT
7865
PUT
AGNT Inc
AGNT
$790M
| $598K | ﹤0.01% |
47,100
-153,100
| -76% | -$2.04M |
|
7866
Fulcrum Therapeutics
FULC
$296M
| $597K | ﹤0.01% |
209,459
-606,785
| -74% | -$5.44M |
|
|
TA
7867
PUT
DELISTED
TravelCenters of America LLC
TA
| $597K | ﹤0.01% |
6,900
-4,600
| -40% | -$302K |
|
7868
PUT
United Microelectronic
UMC
$45.4B
| $597K | ﹤0.01% |
68,100
-447,700
| -87% | -$3.63M |
|
|
PENG
7869
CALL
Penguin Solutions Inc
PENG
$2.8B
| $597K | ﹤0.01% |
34,600
-211,100
| -86% | -$3.53M |
|
7870
Fidelity Stocks for Inflation ETF
FCPI
$286M
| $596K | ﹤0.01% |
18,917
-24,563
| -56% | -$769K |
|
7871
CALL
ACM Research
ACMR
$5.5B
| $596K | ﹤0.01% |
50,900
-10,300
| -17% | -$119K |
|
7872
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $595K | ﹤0.01% |
+11,890
| New | +$585K |
|
7873
PUT
Calix
CALX
$2.5B
| $595K | ﹤0.01% |
11,100
-100
| -0.9% | -$5.45K |
|
7874
Bowman Consulting
BWMN
$738M
| $594K | ﹤0.01% |
20,702
-5,969
| -22% | -$156K |
|
|
TSE
7875
CALL
DELISTED
Trinseo
TSE
| $594K | ﹤0.01% |
28,500
+3,200
| +13% | +$78.3K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.